End-of-day quote
Other stock markets
|
5-day change | 1st Jan Change | ||
8,260 KRW | -1.20% | -6.67% | -41.99% |
May. 23 | Syntekabio to Showcase Advanced AI Drug Discovery Technologies at BIO International Convention 2024 | CI |
May. 07 | Syntekabio Announces to Showcase Biologics Discovery Platform At PEGS Boston | CI |
Business Summary
Sales per Business
KRW in Million | 2022 | Weight | 2023 | Weight | Delta |
---|---|---|---|---|---|
Genome Analysis
100.0
%
| 244 | 100.0 % | 123 | 100.0 % | -49.42% |
Sales per region
KRW in Million | 2022 | Weight | 2023 | Weight | Delta |
---|---|---|---|---|---|
South Korea
100.0
%
| 244 | 100.0 % | 123 | 100.0 % | -49.42% |
Managers
Managers | Title | Age | Since |
---|---|---|---|
Tyson Kim
CEO | Chief Executive Officer | - | 14-12-31 |
Jongsun Jung
FOU | Founder | - | 08-12-31 |
Sunghoon Park
DFI | Director of Finance/CFO | - | - |
Hyeonjin Yang
CTO | Chief Tech/Sci/R&D Officer | - | - |
Yangrae Cho
CTO | Chief Tech/Sci/R&D Officer | - | - |
Maeng Jae Yeourl
SAM | Sales & Marketing | - | - |
Share class
Vote | Quantity | Free-Float | Company-owned shares | Total Float | |
---|---|---|---|---|---|
Stock A | 1 | 15,258,475 | 12,752,528 ( 83.58 %) | 0 | 83.58 % |
Company contact information
1st Jan change | Capi. | |
---|---|---|
-41.99% | 93.43M | |
-20.74% | 937M |
- Stock Market
- Equities
- A226330 Stock
- Company SyntekaBio, Inc.